Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APAF1 | O14727 | 6/20 | 1.00 |
| ▸ | NPC1 | O15118 | 5/20 | 1.00 |
| ▸ | TDP2 | O95551 | 4/20 | 1.00 |
| ▸ | NSD2 | O96028 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 1.00 |
| ▸ | HKDC1 | Q2TB90 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | RAB9A | P51151 | 3/20 | 1.00 |
| ▸ | BLM | P54132 | 2/20 | 1.00 |
| ▸ | GALK1 | P51570 | 1/20 | 1.00 |
| ▸ | ATM | Q13315 | 1/20 | 1.00 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 1.00 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 1.00 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.77 |
| ▸ | S100A4 | P26447 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 10/20 | 0.54 |
| ▸ | HTT | P42858 | 4/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | STAT3 | P40763 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4647391 | 1.00 | APAF1 (1.00) | APAF1NPC1TDP2NSD2KMT2A | |
| SCHEMBL247037 | 0.88 | KMT2A (0.79) | APAF1NPC1TDP2NSD2KMT2A | |
| SCHEMBL7260223 | 0.83 | APAF1 (1.00) | APAF1NPC1TDP2NSD2KMT2A | |
| SCHEMBL4649553 | 0.80 | DNMT1 (0.83) | APAF1NPC1TDP2NSD2KMT2A | |
| SCHEMBL10037145 | 0.80 | DNMT1 (0.77) | APAF1NPC1TDP2NSD2KMT2A | |
| SCHEMBL10446509 | 0.77 | TDP2 (0.73) | APAF1NPC1TDP2NSD2KMT2A | |
| SCHEMBL14566962 | 0.76 | KMT2A (0.61) | APAF1NPC1TDP2NSD2KMT2A | |
| SCHEMBL9508287 | 0.76 | MAPT (0.66) | APAF1NPC1TDP2NSD2KMT2A | |
| SCHEMBL4649478 | 0.73 | APAF1 (0.56) | APAF1NPC1TDP2NSD2KMT2A | |
| SCHEMBL4649480 | 0.73 | APAF1 (0.56) | APAF1NPC1TDP2NSD2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250213601-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR THE TREATMENT OF VIRAL DISEASES | Didenko, Kirill (US) | 2025-07-03 | — | — | US | disclosed |
| CN-120091810-A | Methods and highly bioavailable permeable compounds for treating viral diseases | 基里尔·迪丹克 | 2025-06-03 | — | — | CN | disclosed |
| WO-2023187599-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR THE TREATMENT OF VIRAL DISEASES | DIDENKO KIRILL (MX) | 2023-10-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250213601-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR THE TREATMENT OF VIRAL DISEASES | ACE2, FURIN, SARS1 | APAF1 2334/4885NPC1 23/4885TDP2 683/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.